ropivacaine hydrochloride
Generic: ropivacaine hydrochloride
Labeler: baxter healthcare corporationDrug Facts
Product Profile
Brand Name
ropivacaine hydrochloride
Generic Name
ropivacaine hydrochloride
Labeler
baxter healthcare corporation
Dosage Form
INJECTION, SOLUTION
Routes
Active Ingredients
ropivacaine hydrochloride 2 mg/mL
Manufacturer
Identifiers & Regulatory
Product NDC
43066-152
Product ID
43066-152_fd79ad2e-1298-4643-bcb5-453b3bffe22a
Product Type
HUMAN PRESCRIPTION DRUG
Marketing Category
ANDA
Application Number
ANDA210102
Listing Expiration
2026-12-31
Marketing Start
2024-01-01
Pharmacologic Class
Classes
Normalized Code Variants
Searchable formats for this product NDC code
Digits Only
43066152
Hyphenated Format
43066-152
Supplemental Identifiers
RxCUI
UNII
Packaging Origin
Original Packager
Resolved Product View
Precedence rule: structured NDC data is preferred, falling back to linked label metadata when unavailable. Source tags show the origin of each value.
Resolved Identity
Brand Name
ropivacaine hydrochloride (source: ndc)
Generic Name
ropivacaine hydrochloride (source: ndc)
Application Number
ANDA210102 (source: ndc)
Routes
source: ndc
Resolved Composition
Strengths
- 2 mg/mL
Packaging
- 10 BAG in 1 CARTON (43066-152-10) / 100 mL in 1 BAG (43066-152-01)
Packages (1)
Ingredients (1)
Linked Drug Pages (1)
Raw FDA Data
View complete raw FDA NDC JSON payload
{"route": ["EPIDURAL", "INFILTRATION"], "spl_id": "fd79ad2e-1298-4643-bcb5-453b3bffe22a", "openfda": {"unii": ["V910P86109"], "rxcui": ["1734347", "1734355"], "spl_set_id": ["e057aeb2-5125-490c-b691-847426fd42d0"], "manufacturer_name": ["Baxter Healthcare Corporation"], "is_original_packager": [true]}, "finished": true, "packaging": [{"sample": false, "description": "10 BAG in 1 CARTON (43066-152-10) / 100 mL in 1 BAG (43066-152-01)", "package_ndc": "43066-152-10", "marketing_start_date": "20240101"}], "brand_name": "ROPIVACAINE HYDROCHLORIDE", "product_id": "43066-152_fd79ad2e-1298-4643-bcb5-453b3bffe22a", "dosage_form": "INJECTION, SOLUTION", "pharm_class": ["Amide Local Anesthetic [EPC]", "Amides [CS]", "Local Anesthesia [PE]"], "product_ndc": "43066-152", "generic_name": "ROPIVACAINE HYDROCHLORIDE", "labeler_name": "Baxter Healthcare Corporation", "product_type": "HUMAN PRESCRIPTION DRUG", "brand_name_base": "ROPIVACAINE HYDROCHLORIDE", "active_ingredients": [{"name": "ROPIVACAINE HYDROCHLORIDE", "strength": "2 mg/mL"}], "application_number": "ANDA210102", "marketing_category": "ANDA", "marketing_start_date": "20240101", "listing_expiration_date": "20261231"}